Health

Kokilaben Hospital’s CSR Initiatives: Bridging Gaps in Healthcare and changing Lives

by Suman Gupta

Shri Nitin Gadkari, Minister for Road Transport & Highways, Government of India is Guest of Honour

Mumbai, November 3, 2023: Kokilaben Dhirubhai Ambani Hospital, organised a special session on ‘Thalassemia, Way Forward’ today. The event underlined the organisation’s larger approach that complements technology, expertise, robust infrastructure, and strategic investments in fostering partnerships with entities contributing significantly to healthcare initiatives. Though the event categorically aimed to shed light on the progressive strides in treating Thalassemia, a genetic blood disorder, and to amplify awareness of government schemes designed to aid patients grappling with this condition. The distinguished Guest of Honour for the occasion was Shri Nitin Gadkari, Minister of Road Transport & Highways, Government of India, whose presence underscored the collaboration between the public and private sectors in advancing healthcare.

On the occasion, Ms. Tina Ambani, Chairperson, Kokilaben Dhirubhai Ambani Hospital outlined the way forward for the Thalassemia Project, and said ” With ability comes responsibility, and we have made it our responsibility to ensure we do all in our power to offer every child the best treatment we can. As we expand our footprint across the region and into the hinterland, our roots in the communities we serve are going deeper. And our resolve to widen the embrace of care has become stronger. That resolve lies at the heart of ‘Every Life Matters’, which is the underlying principle behind all that we do.”

Thalassemia causes severe anaemia, fatigue, and various complications, necessitating lifelong blood transfusions and extensive medical therapy. India witnesses a high prevalence of Thalassemia, with over 10,000 children born with this condition annually.  The only treatment that can permanently cure thalassaemia is Stem Cell Transplantation, also known as Bone Marrow Transplantation. Known as an allogenic BMI, it’s a complex process and very few centres around the world have the expertise to conduct this treatment.

 Shri Nitin Gadkari, Minister of Road Transport & Highways, Government of India said “Today is a day of reflection for me. The constituency I represent, as well as the northern part of Nagpur, collectively has about 80,000 thalassemia patients. Raising awareness about the risks of consanguineous marriages, especially among disadvantaged communities, is crucial. Kokilaben Dhirubhai Ambani  Hospital’s initiative is a commendable step in addressing Maharashtra’s Thalassemia burden. I appreciate all the stakeholders in this collaborative effort.”

Kokilaben Hospital is also privileged to support the Coal India CSR-funded Hematopoietic Stem Cell Transplant (HSCT) programme and help underprivileged Thalassemia patients who do not have the financial resources to cover the cost of the program. In June this year, the hospital extended the MoU with Coal India for the third phase of their Corporate Social Responsibility (CSR) project, the Thalassemia Bal Sewa Yojana, aimed at curative treatment of Thalassemia and Aplastic Anaemia in children from an underprivileged background. This is helping to extend the reach of life-saving BMT treatments to more disadvantaged children affected by Thalassemia and Aplastic Anaemia.

Kokilaben Dhirubhai Ambani Hospital continues to remain steadfast in its commitment to spearheading initiatives that offer hope, care, and the promise of a healthier society. It has been at the forefront in supporting the underprivileged access the best of modern healthcare by supporting Corporate Social Responsibility (CSR) activities. The hospital has collaborated with Rashtriya Bal Swasthya Karyakram (RBSK) and the Government of Maharashtra, performing over 126 successful Cochlear implant surgeries for economically disadvantaged children.

Under the ‘Healing Little Hearts’ initiative, the hospital has been instrumental in treating children from economically weaker sections suffering from congenital heart diseases. The hospital’s Clubfoot Clinic has also been pivotal in providing essential treatment, ensuring that children do not suffer from mobility issues due to clubfoot.

Related posts

Glenmark becomes the First Companyin India to launchTeneligliptin + Dapagliflozin 

World Health Day (7th April) : Ms. Ameera Shah, Managing director and Promoter, Metropolis Healthcare Ltd.

Sarthak Educational Trust unfolds the road ahead for disability empowerment in the country post COVID 19

Leave a Comment

77 − 69 =